🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06991088
Starting soon Observational

Chinese Cardiologists' Knowledge/Practices on Flu Vaccine for Chronic Coronary Syndrome

NCT06991088 · tracked via the Priya Life Science China tracker
Sponsor
The Affiliated Hospital of Hangzhou Normal University
Phase
Observational
Started
2025-06
Last updated
2025-06-04

Condition(s) studied

Chinese Cardiologists

Study summary

This long-term single-center cross-sectional study evaluates physicians' knowledge of influenza vaccination in CCS patients through collected feedback, while identifying knowledge gaps and misconceptions regarding vaccination. By analyzing factors influencing physicians' recommendation practices, it provides evidence to guide future educational and policy interventions. Ultimately, the study aims to enhance cardiologists' vaccination awareness, thereby optimizing CCS patient management and reducing influenza-associated complications and mortality.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
No
Inclusion Criteria: Cardiologists (licensed practitioners) with specialized knowledge of the association between influenza vaccination and cardiovascular diseases. Exclusion Criteria: * Physicians from non-cardiology specialties (e.g., surgery, general internal medicine \[including respiratory and gastroenterology departments\], emergency medicine). * Physicians unable to complete the questionnaire survey.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
MingWei Wang Hanzhou Zhejiang

More The Affiliated Hospital of Hangzhou Normal University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06991088 on ClinicalTrials.gov ↗ ← All trials in China